Update on the clinical applications of argatroban | Future Cardiology
High-dose Argatroban Therapy for Stroke: Novel Treatment for Delayed Treatment and the Recanalization Mechanism - Journal of Stroke and Cerebrovascular Diseases
Bivalent direct thrombin inhibitors: hirudin and bivalirudin - ScienceDirect
Bivalent direct thrombin inhibitors: hirudin and bivalirudin - ScienceDirect
Bivalirudin: a direct thrombin inhibitor used during percutaneous coronary intervention | Future Cardiology
REBEL EM - Some Anticoagulation Meds I don't typically use in the ED, but am using up in the ICU: Bivalirudin -Half-Life = 25min (with normal renal function) -Mechanism of Action =
Medicines | Free Full-Text | Direct-Acting Oral Anticoagulants and Their Reversal Agents—An Update | HTML
Perfusion Policies 101: Agatroban - Perfusion.com
PDF] Comparison of bivalirudin to lepirudin and argatroban in patients with heparin-induced thrombocytopenia. | Semantic Scholar
Bivalirudin resistance in a patient on veno-venous extracorporeal membrane oxygenation with a therapeutic response to argatroban | BMJ Case Reports
The Use of Bivalirudin in Pediatric Cardiac Surgery and in the Interventional Cardiology Suite - Journal of Cardiothoracic and Vascular Anesthesia
Figure 2 | Synthesis and biocompatibility of an argatroban-modified polysulfone membrane that directly inhibits thrombosis | SpringerLink
Argatroban Anticoagulant Therapy in Patients With Heparin-Induced Thrombocytopenia | Circulation